Arcadia Biosciences (RKDA) Enterprise Value (2014 - 2025)

Arcadia Biosciences has reported Enterprise Value for 12 years, with the latest figure at -$4.6 million in Q4 2025.

• For the quarter ending Q4 2025, Enterprise Value fell 8.53% year-over-year to -$4.6 million; the trailing twelve-month figure through Dec 2025 stood at -$4.6 million (down 8.53% YoY), and the FY2025 full-year result was -$4.6 million, down 8.53% from the prior year.
• Enterprise Value for Q4 2025 stood at -$4.6 million, up from -$5.9 million in the prior quarter.
• The five-year high for Enterprise Value was -$3.2 million in Q1 2025, with the low at -$50.7 million in Q1 2021.
• Historically, Enterprise Value has averaged -$18.1 million across 5 years, with a median of -$17.2 million in 2023.
• Annual changes were most pronounced in 2021 — Enterprise Value tumbled 378.73% — and 2024, when it soared 63.99%.
• Arcadia Biosciences' Enterprise Value stood at -$28.6 million in 2021, then gained by 27.31% to -$20.8 million in 2022, then soared by 43.3% to -$11.8 million in 2023, then jumped by 63.99% to -$4.2 million in 2024, then slipped by 8.53% to -$4.6 million in 2025.
• The last three Enterprise Value figures came in at -$4.6 million (Q4 2025), -$5.9 million (Q3 2025), and -$4.5 million (Q2 2025), per Business Quant data.